These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6422442)

  • 21. Use of 42 MeV betatron bremsstrahlung irradiation in the therapy combined with radium in carcinoma of the cervix.
    Tacev T; Krystof V; Spurný V; Ott O; Caha A; Milír A; Kucera F; Ptácková B; Kabela M
    Czech Med; 1981; 4(1-2):32-42. PubMed ID: 6790256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of HDR afterloading with 192Ir versus conventional radium therapy in cervix cancer: 5-year results and complications.
    Glaser FH
    Sonderb Strahlenther Onkol; 1988; 82():106-13. PubMed ID: 3134704
    [No Abstract]   [Full Text] [Related]  

  • 23. [Simplified HDR-afterloading and high-voltage therapy of cervical carcinoma].
    Hetzel H; Fritsch E; Url M; Frommhold H; Dapunt O
    Strahlenther Onkol; 1987 Dec; 163(12):774-81. PubMed ID: 3122347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of radiotherapy of cervix cancer].
    Schwarz R
    Zentralbl Gynakol; 1993; 115(12):537-40. PubMed ID: 8147165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High dose-rate afterloading in the treatment of carcinoma of the cervix, 5-year results of an unusual fractionation technique.
    Bates TD
    Sonderb Strahlenther Onkol; 1988; 82():162-5. PubMed ID: 3134713
    [No Abstract]   [Full Text] [Related]  

  • 26. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of stage III carcinoma of the uterine cervix treated by conformation radiotherapy].
    Morita K; Watanabe M; Fuwa N
    Gan No Rinsho; 1986 Apr; 32(4):371-8. PubMed ID: 3086598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surgical intervention for the central recurrence or persistent local lesion of uterine cervical carcinoma following full-dose radiotherapy].
    Bai P; Ma Y; Li W; Zhang R
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):52-5. PubMed ID: 20211069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
    Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
    Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physical agents in the treatment of malignant tumors of the uterus].
    Chenal C
    Soins; 1980 Jan; 25(2):17-25. PubMed ID: 6767279
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results of electron therapy with convergent lens in preoperative focalized treatment uterine cervix cancer at stage].
    Paschetta C; Paschetta V; Prat PP; Scholem P
    J Radiol Electrol Med Nucl; 1972 Jan; 53(1):82-3. PubMed ID: 4624925
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness of fractionated dose schedules in the intracavitary gamma-therapy of cervical cancer].
    Vishnevskaia EE; Minenko VF
    Med Radiol (Mosk); 1982 Jun; 27(6):7-11. PubMed ID: 7109868
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radiotherapy and brachytherapy in advanced cancers of the cervix].
    Haie-Meder C; Lartigau E; Gerbaulet A
    Bull Cancer Radiother; 1996; 83(4):360-3. PubMed ID: 9081338
    [No Abstract]   [Full Text] [Related]  

  • 34. Supervoltage radiation treatment in advanced cancer of the uterine cervix. A preliminary report.
    Allt WE
    Can Med Assoc J; 1969 May; 100(17):792-7. PubMed ID: 4976329
    [No Abstract]   [Full Text] [Related]  

  • 35. [Automated calculation of optimum dose distribution and irradiation condition for intracavitary treatment of uterine cervix carcinoma].
    Tabushi K; Itoh S; Sakura M; Nakamura YK; Iinuma T; Arai T; Nagai T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Jul; 42(7):669-82. PubMed ID: 7145623
    [No Abstract]   [Full Text] [Related]  

  • 36. Present status of brachytherapy, especially HDR afterloading in Japan.
    Morita K; Uchiyama Y
    Sonderb Strahlenther Onkol; 1988; 82():16-21. PubMed ID: 3134712
    [No Abstract]   [Full Text] [Related]  

  • 37. [Relationship between central recurrence and time-dose factors in patients with carcinoma of uterine cervix after radiotherapy].
    Gao JZ
    Zhonghua Zhong Liu Za Zhi; 1989 Sep; 11(5):394-7. PubMed ID: 2515955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-year results and complications following high intensity afterloading technique (CTR).
    Ilić S; Ristić B
    Sonderb Strahlenther Onkol; 1988; 82():123-6. PubMed ID: 3134707
    [No Abstract]   [Full Text] [Related]  

  • 39. Carcinoma of the cervix: radiotherapy. Low dose-rate of endocavitary brachytherapy.
    Chassagne DJ
    Proc R Soc Med; 1973 Sep; 66(9):936-8. PubMed ID: 4805102
    [No Abstract]   [Full Text] [Related]  

  • 40. [Preoperative low-dose-rate brachytherapy in cervix carcinoma: acute side effects in relation to the dosage rate].
    Roth SL
    Strahlenther Onkol; 1994 Dec; 170(12):720-2. PubMed ID: 7817276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.